美國Mesenchymal Stem Cells 大鼠骨髓間質干細胞
美國PrimCells干細胞：PrimCells提供多種報告基因敲進的小鼠胚胎干細胞，該類細胞皆在原始基因座上敲入熒光報告基因，從而使熒光蛋白的表達能真實反映原基因座附近的表達調控狀況。該類細胞作為研究胚胎干細胞自更新和定向分化的有力工具，受到多家*研究所研究人員的青睞。
Introduction:
Mesenchymal stem cells (MSC) are a population of well characterized adult stem cells. Under proper induction, they can differentiate into many cell types including fat, cartilage, bone, tendons, and muscle1, 2. Due to their differentiation capacities, there is a growing interest in in the potential use of these cells for regenerative medicine.
PrimCells is proud to offer mesenchymal stem cells isolated from bone marrow of Sprague Dawley rats. These cells are cryopreserved at very early passages (1-2) and can maintain their pluripotency under suggested conditions for at least 3-4 passages. They are positive with CD44, CD90, CD29 and have been routinely tested for their differentiation abilities. They will be your ideal choice for your MSC related researches.
Figure 1 | Bright field image of Rat MSCs from bone marrow
Figure 2 | Adipocytes differentiated from rat MSC-BM at Day18
美國PrimCells品牌介紹
PrimCells是位于美國加州圣迭戈的一家專業(yè)致力于細胞產品研發(fā)和解決方案提供的業(yè)內技術。
公司匯集了*的生物醫(yī)藥技術專家，獨立開發(fā)了多項原代細胞和干細胞相關的專有技術。 公司以“細胞研究的*選擇”為宗旨，自主研發(fā)超過70種創(chuàng)新產品，*多個特種細胞市場的空白。例如其誘導性表達細胞庫和高效3D皮膚培養(yǎng)系統(tǒng)，皆為該類產品目前市場上少數(shù)的規(guī)模化供應商。此外，公司以高質量的數(shù)據與快速穩(wěn)定的項目完成時間，長期為多家制藥公司提供解決方案，獲得用戶廣泛贊譽。
PrimCells產品線：
1. 報告基因干細胞 2. 原代細胞（含報告基因原代細胞） 3. 誘導性穩(wěn)定細胞株
4. 人源重組蛋白 5. 創(chuàng)新型培養(yǎng)試劑
PrimCells 解決方案
1.誘導性穩(wěn)定細胞株開發(fā) 2. 原代細胞開發(fā) 3. 藥物體外毒理和效能測試 4. 3D-皮膚培養(yǎng)
PrimCells合作伙伴及客戶:
A．生物制藥公司：輝瑞(Pfizer), 諾華(Novartis), 禮來(Eli2 Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和醫(yī)藥研發(fā)部門
B．科研機構：冷泉港實驗室，哈佛醫(yī)學院, 麻省理工（MIT）,， UCSF, NYU, Salk, UIUC, USC等
14
